Literature DB >> 8656627

Mechanism of protection of verapamil by preventing neutrophil infiltration in the ischemic rat kidney.

F López-Neblina1, A J Páez-Rollys, L H Toledo-Pereyra.   

Abstract

In this study, we tested if the mechanism of protection of a calcium channel blocker, Verapamil (VER), was due to modulation of neutrophil infiltration after ischemia/reperfusion injury, in a rat renal ischemic model. Forty-four Sprague-Dawley rats were subjected to 75 min of warm ischemia and immediate contralateral nephrectomy. The animals were divided into two groups: the ischemic control (IC) group, which received normal saline, and the experimental group that received VER 1.25 mg/kg. The drug was administrated intravenously after ligation of the renal pedicle, before reperfusion. Survival was followed for 7 days. Laboratory tests included renal function tests, with serum creatinine (SCr) and blood urea nitrogen (BUN), light histology and neutrophil infiltration, measured by the myeloperoxidase test in renal tissue. Better survival rate was observed in the VER group (85% at 7 days vs control 50%) (P = 0.08). SCr and BUN at 48 and 72 hr showed a statistical significant difference between the two groups (VER lower than IC P < 0.05). Histological damage was significantly less in the VER group (P < 0.05). Neutrophil infiltration was significantly decreased in the VER group when compared to the IC group (P < 0.05). We concluded then, that VER had a downregulating effect on neutrophil infiltration and this might be an important mechanism of protection during the development of renal ischemic damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8656627     DOI: 10.1006/jsre.1996.0148

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  Novel mode of action of the calcium antagonist mibefradil (Ro 40-5967): potent immunosuppression by inhibition of T-cell infiltration through allogeneic endothelium.

Authors:  R A Blaheta; N P Hailer; N Brude; B Wittig; E Oppermann; K Leckel; S Harder; M Scholz; S Weber; A Encke; B H Markus
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

2.  Biological and histopathological investigations of moclobemide on injured ovarian tissue following induction of ischemia-reperfusion in rats.

Authors:  Metin Ingec; Muhammet Calik; Cemal Gundogdu; Ali Kurt; Mehmet Yilmaz; Unal Isaoglu; Suleyman Salman; Fatih Akcay; Halis Suleyman
Journal:  Int J Fertil Steril       Date:  2012-06-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.